Company Overview of Optherion, Inc.
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.
555 Long Wharf Drive
The Maritime Center
New Haven, CT 06511
Founded in 2005
Key Executives for Optherion, Inc.
Similar Private Companies By Industry
|Ophtalox, Inc.||United States|
|Difco Laboratories Incorporated||United States|
|Kineta Holdings II, LLC||United States|
|Transfusion & Transplantation Technologies, Inc.||United States|
|Aixlie Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Optherion, Inc., please visit www.optherion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.